Release 5 Ballot
Clinical ReasoningThis page is part of the FHIR Specification (v5.0.0-ballot: R5 Ballot - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
| Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Certainty Rating of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19
{
"resourceType": "ArtifactAssessment",
"id": "example-certainty-rating",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ArtifactAssessment</b><a name=\"example-certainty-rating\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ArtifactAssessment "example-certainty-rating" </p></div><p><b>identifier</b>: FEvIR Object Identifier: 27756</p><p><b>date</b>: 2021-11-02T14:48:59.89Z</p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>artifact</b>: <a href=\"broken-link.html\">Evidence/18812: Critically appraised summary of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: rating</p><p><b>summary</b>: serious concerns with risk of bias, inconsistency, and imprecision</p><p><b>type</b>: Overall certainty <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#Overall)</span></p><p><b>classifier</b>: Very low quality <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#very-low)</span></p><p><b>author</b>: <span>: Brian S. Alper</span></p><p><b>freeToShare</b>: true</p><h3>Components</h3><table class=\"grid\"><tr><td>-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td><td><b>Author</b></td></tr><tr><td>*</td><td>rating</td><td>risk of bias in both included trials</td><td>Risk of bias <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#RiskOfBias)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td>high degree of heterogeneity (I-squared 80.7%) with confidence intervals of 2 trial effect estimates barely overlapping</td><td>Inconsistency <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#Inconsistency)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td> </td><td>Indirectness <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#Indirectness)</span></td><td>no serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#no-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td>95% confidence interval includes both large effects and no effects</td><td>Imprecision <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#Imprecision)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td> </td><td>Publication bias <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">EvidenceCertaintyType</a>#PublicationBias)</span></td><td>no serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">EvidenceCertaintyRating</a>#no-concern)</span></td><td><span>: Brian S. Alper</span></td></tr></table></blockquote></div>"
},
"identifier": [
{
"type": {
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net",
"value": "27756",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"date": "2021-11-02T14:48:59.890Z",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"artifactReference": {
"reference": "Evidence/18812",
"type": "Evidence",
"display": "Critically appraised summary of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19"
},
"content": [
{
"informationType": "rating",
"summary": "serious concerns with risk of bias, inconsistency, and imprecision",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "Overall",
"display": "Overall certainty"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "very-low",
"display": "Very low quality"
}
]
}
],
"author": {
"display": "Brian S. Alper"
},
"freeToShare": true,
"component": [
{
"informationType": "rating",
"summary": "risk of bias in both included trials",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "RiskOfBias",
"display": "Risk of bias"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "serious-concern",
"display": "serious concern"
}
]
}
],
"author": {
"display": "Brian S. Alper"
}
},
{
"informationType": "rating",
"summary": "high degree of heterogeneity (I-squared 80.7%) with confidence intervals of 2 trial effect estimates barely overlapping",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "Inconsistency",
"display": "Inconsistency"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "serious-concern",
"display": "serious concern"
}
]
}
],
"author": {
"display": "Brian S. Alper"
}
},
{
"informationType": "rating",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "Indirectness",
"display": "Indirectness"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "no-concern",
"display": "no serious concern"
}
]
}
],
"author": {
"display": "Brian S. Alper"
}
},
{
"informationType": "rating",
"summary": "95% confidence interval includes both large effects and no effects",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "Imprecision",
"display": "Imprecision"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "serious-concern",
"display": "serious concern"
}
]
}
],
"author": {
"display": "Brian S. Alper"
}
},
{
"informationType": "rating",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-type",
"code": "PublicationBias",
"display": "Publication bias"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/certainty-rating",
"code": "no-concern",
"display": "no serious concern"
}
]
}
],
"author": {
"display": "Brian S. Alper"
}
}
]
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-ballot generated on Sat, Sep 10, 2022 05:01+1000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change